 |
 |
 |
|
E-mail your letter to the editor
|
|
 |
|
|
|
|
 |
| CHRIS BJORNBERG/PHOTO RESEARCHERS |
|
TAMOXIFEN
Most women treated for breast cancer take tamoxifen to prevent the cancer from recurring, but it seems that for the drug to be most effective, timing is key. Until last year, most women with early-stage, estrogen-sensitive breast cancer had surgery followed by chemotherapy and tamoxifen. Tamoxifen blocks estrogen's cancer-promoting effects, but it turns out that the drug keeps chemotherapy agents from penetrating cancer cells and destroying them. An eight-year study of breast-cancer patients showed that women who waited to take tamoxifen until after their chemotherapy cycles were complete were 18% more likely to survive without a recurrence of cancer than women who took the two treatments together.
Related Sources:
American Society of Clinical Oncology annual meeting (May 2002)
 |
 |
|
NATION
 Can This War Be Avoided?
Many push for alternatives. But those who know Bush say, Don't bet on it
NATION
Get Ready for Class Warfare
Critics say Bush's plan outrageously favors the rich. The President says nonsense, everyone gets a break. But here's the question worth exploring:
Does the economy win or lose in all this
arm wrestling?
|
|
BUSINESS
Tight Skivvies
They're what everyone's wearing this season. Here's why
ARTS
What They Really Want Is to Direct
Big-name stars like George Clooney, Nicolas Cage and Denzel Washington are using their box-office clout to get their shot behind the camera
|
|
|
|
|
|
|
|
|
